Procter & Gamble (NYSE:PG) Stock Price Down 1.1% – Here’s What Happened

Procter & Gamble Company (The) (NYSE:PG)’s stock price traded down 1.1% on Wednesday . The stock traded as low as $141.66 and last traded at $142.3410. 6,671,502 shares traded hands during mid-day trading, a decline of 37% from the average session volume of 10,646,760 shares. The stock had previously closed at $143.91.

Analyst Upgrades and Downgrades

A number of brokerages have commented on PG. Piper Sandler increased their price target on shares of Procter & Gamble from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Friday, April 24th. UBS Group raised their target price on shares of Procter & Gamble from $166.00 to $172.00 and gave the company a “buy” rating in a research note on Monday, April 27th. Erste Group Bank downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Tuesday, March 24th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $163.00 target price on shares of Procter & Gamble in a research note on Monday, April 27th. Finally, Evercore set a $162.00 price target on Procter & Gamble in a research note on Monday, April 27th. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $161.06.

Procter & Gamble Stock Performance

The firm has a market capitalization of $331.46 billion, a price-to-earnings ratio of 20.81, a PEG ratio of 6.15 and a beta of 0.41. The company has a fifty day moving average of $147.20 and a two-hundred day moving average of $148.40. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.53 and a current ratio of 0.73.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, April 24th. The company reported $1.59 EPS for the quarter, beating analysts’ consensus estimates of $1.56 by $0.03. The firm had revenue of $21.24 billion for the quarter, compared to analyst estimates of $21.52 billion. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 24th will be paid a $1.0885 dividend. This represents a $4.35 annualized dividend and a dividend yield of 3.1%. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.06. The ex-dividend date is Friday, April 24th. Procter & Gamble’s dividend payout ratio is currently 63.60%.

Insiders Place Their Bets

In other Procter & Gamble news, CEO Gary A. Coombe sold 36,093 shares of the business’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $162.33, for a total value of $5,858,976.69. Following the completion of the sale, the chief executive officer owned 34,994 shares of the company’s stock, valued at $5,680,576.02. The trade was a 50.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Ma. Fatima Francisco sold 5,549 shares of the stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $165.29, for a total transaction of $917,194.21. Following the transaction, the chief executive officer owned 1,029 shares in the company, valued at approximately $170,083.41. The trade was a 84.36% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 220,852 shares of company stock worth $35,880,848. 0.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Procter & Gamble

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Measured Wealth Private Client Group LLC raised its holdings in Procter & Gamble by 8.3% in the 1st quarter. Measured Wealth Private Client Group LLC now owns 1,642 shares of the company’s stock valued at $237,000 after acquiring an additional 126 shares in the last quarter. Signature Equity Partners LLC grew its holdings in shares of Procter & Gamble by 11.0% during the 1st quarter. Signature Equity Partners LLC now owns 5,823 shares of the company’s stock worth $841,000 after purchasing an additional 575 shares in the last quarter. Alpha Financial Partners LLC bought a new position in shares of Procter & Gamble in the first quarter worth $270,000. Alesco Advisors LLC An ESL Co raised its stake in Procter & Gamble by 1.9% in the first quarter. Alesco Advisors LLC An ESL Co now owns 5,091 shares of the company’s stock valued at $735,000 after purchasing an additional 93 shares in the last quarter. Finally, First Trust Advisors LP raised its stake in Procter & Gamble by 6.5% in the first quarter. First Trust Advisors LP now owns 1,767,050 shares of the company’s stock valued at $255,233,000 after purchasing an additional 107,640 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.